Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants
Multicenter Trials to Evaluate the Efficacy and Toxicity of Sirolimus/Tacrolimus Combination as a GVHD Prophylaxis After HLA Matched Related PBSCT
Sponsor: Asan Medical Center
A PHASE2 clinical study on Acute Leukemia in Remission and Leukemia, Myeloid, Accelerated-Phase, this trial is terminated or withdrawn. The trial is conducted by Asan Medical Center and has accumulated 10 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE2
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE2
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE2
-
Jan 2017 — Aug 2017 [monthly]
Terminated PHASE2
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asan Medical Center
- Chonbuk National University Hospital
- Chonnam National University Hospital
- Chung-Ang University Hosptial, Chung-Ang University College of Medicine
- Daegu Catholic University Medical Center
- Ewha Womans University Mokdong Hospital
- Gachon University Gil Medical Center
- Inha University Hospital
- Inje University
- Keimyung University Dongsan Medical Center
- Korea University Anam Hospital
- Pusan National University Hospital
- Samsung Medical Center
- Seoul National University Hospital
- Seoul St. Mary's Hospital
- Severance Hospital
- Soonchunhyang University Hospital
- The Korean Society of Blood and Marrow Transplantation
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Bucheon-si, South Korea